FineHeart
PrivateLast Round
Series C
Jan 9, 2026
Total Funding Raised
$75.41M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
FineHeart is a medical device company that develops the FLOWMAKER®, a wirelessly powered, fully implantable mechanical circulatory support device for patients with severe heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FineHeart Comparables
Compare FineHeart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorWave | 91% | |
| BrioHealth Solutions | 81% | |
| Puzzle Medical Devices Inc. | 79% |
FineHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 9, 2026 | ||||
| Grant | Oct 19, 2022 | ||||
| Series B Extension | Dec 15, 2021 | ||||
| Series B | Jun 1, 2021 | ||||
| Series A | Mar 21, 2016 |
Key People
Founding team and executive leadership
FineHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series C |
| Verve Ventures | Series B Extension, Series B |
| European Commission | Grant |
| Verve Capital | Series C |
| Aqui-Invest | Series A |
| Groupe Pasteur Mutualité | Series C |
| UI Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 49, 5.2x the trailing average.
- Feb 1, 2026
Monthly visitors grew 191% MoM, reaching 2.6K.
FineHeart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FineHeart's valuation, stock price, and market status.
Is FineHeart a public or private company?
FineHeart is a private company.
What is the current stock price of FineHeart?
FineHeart is a private company with no public stock price. No recent secondary market data is available.
How much is FineHeart worth (valuation)?
Valuation information for FineHeart is not publicly available.
Can I buy FineHeart stock?
FineHeart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FineHeart's last funding round?
FineHeart's most recent funding round was Series C on January 9, 2026.
Who are the main investors in FineHeart?
Key investors in FineHeart include Doliam, Broadview Ventures.
Will FineHeart IPO soon?
No public IPO plans have been announced for FineHeart.
How can I track FineHeart secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FineHeart's secondary market activity and sign up for updates.